Executive Summary On March 31, 2026, Eli Lilly announced a definitive agreement to acquire Centessa Pharmaceuticals (NASDAQ: CNTA) for up to $7.8 billion ($6.3B upfront + $1.5B in CVRs), representing a 70% premium to the prior close. The acquisition targets Centessa's orexin receptor 2 (OX2R) agonist
The Iranian strikes on Qatar's Ras Laffan complex have removed ~17% of global LNG capacity for 3–5 years, and the broader Middle East conflict has temporarily spiked oil to $100+/bbl — but the structural aftermath overwhelmingly favors the United States across every major economic vector: energy, petrochemicals,
A Simple Explanation of How SOD Sciences Inc. Is Attacking the Root Cause of America's Biggest Health Problem The Problem: We're Spending Trillions Treating the Wrong Thing Almost 90 cents of every dollar the U.S. spends on healthcare, roughly $4.9 trillion a year, goes
A Historical Parallel With a Deadly Twist In 1926, President Calvin Coolidge faced a confrontation with Mexico's President Calles over oil nationalization that bears remarkable structural similarities to today's US-Iran crisis. Both involve a resource-rich nation attempting to use control over critical commodities as leverage against